Anti-Human ABCG2 Polyclonal Antibody

Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain. May be involved in brain-to-blood efflux. Appears to play a major role in the multidrug resistance phenotype of several cancer cell lines. When overexpressed, the transfected cells become resistant to mitoxantrone, daunorubicin and doxorubicin, display diminished intracellular accumulation of daunorubicin, and manifest an ATP-dependent increase in the efflux of rhodamine 123.
List Price: $398
  • Buy 5 for $378.1 each and save 5%
  • Buy 21 for $358.2 each and save 10%
  • Buy 31 for $338.3 each and save 15%
  • Buy 51 for

Properties

Data Sheet Click for Datasheet
Catalog Number PA02947
Size 100μl
Host Type Rabbit
Immunogen Synthesized peptide derived from the Internal region of human ABCG2.
Specificity Highly expressed in placenta. Low expression in small intestine, liver and colon.
Isotype IgG
Reacitivity Human
Clone
Uniprot Q9UNQ0
Concentration 1mg/mL
Dilution WB 1:500-1:2000, IHC 1:100-1:300, ELISA 1:10000
Formulation
Application WB,IHC-p,ELISA
Other Names ABC transporter,ABC15,ABCG 2,ABCG2,ABCG2,ABCP,ATP binding cassette sub family G (WHITE) member 2,ATP binding cassette transporter G2,ATP-binding cassette sub-family G member 2,BCRP,BCRP1,BMDP,Breast cancer resistance protein,CD338,CDw338,CDw338 antigen,EST157481,GOUT1,MGC102821,Mitoxantrone resistance associated protein,Mitoxantrone resistance-associated protein,MRX,Multi drug resistance efflux transport ATP binding cassette sub family G (WHITE) member 2,MXR,MXR1,Placenta specific ATP binding cassette transporter,Placenta specific MDR protein,Placenta-specific ATP-binding cassette transporter,UAQTL1
Storage Lyophilized product: 5 years at 2 - 8°C; Solution: 2 years at -20°C.
Postscript For research use only, not for use in diagnostic procedures.

© Copyright 2024 TZYBIOTECH. All Rights Reserved. SiteMap